Impact of Maternal and Infant Antiretroviral Drug Regimens on Drug Resistance in HIV-infected Breastfeeding Infants
Jessica M. Fogel(Johns Hopkins University), Susan H. Eshleman(Johns Hopkins University), Dhayendre Moodley(Centre for the AIDS Programme of Research in South Africa), Michel Alexandre(Muhimbili University of Health and Allied Sciences), Sheryl Zwerski(National Institutes of Health), Anthony Mwatha(Fred Hutch Cancer Center), Kathleen George(Family Health International 360), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Elizabeth R. Brown(Fred Hutch Cancer Center), Ali Elbireer(African Society for Laboratory Medicine), Paul Richardson(Johns Hopkins University), Tsungai Chipato(University of Zimbabwe-University of California San Francisco), Hoosen Coovadia(University of KwaZulu-Natal), Mark Mirochnick(Government of the United States of America)
Cited by 43
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896